PhaseBio Pharmaceuticals Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Malvern, PA
SEC filing record 1 source field available
Fiscal year end
31 December
PhaseBio Pharmaceuticals Inc has filed 371 SEC EDGAR filings since 25 Feb 2002

SEC filing history

Showing 1-25 of 364 matching filings.

Per page
25
Current page
1
15-12G File 001-38697

15-12G

Filing date
30 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-230504

S-8 POS

Filing date
30 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-262185

S-8 POS

Filing date
30 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-254268

S-8 POS

Filing date
30 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-237462

S-8 POS

Filing date
30 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-227935

S-8 POS

Filing date
30 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-38697

NT 10-Q

Filing date
15 Aug 2024
Reporting date
30 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-38697

NT 10-Q

Filing date
16 May 2024
Reporting date
31 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 001-38697

NT 10-K

Filing date
02 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-38697

NT 10-Q

Filing date
15 Nov 2023
Reporting date
30 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-38697

NT 10-Q

Filing date
25 Aug 2023
Reporting date
30 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 May 2023
Reporting date
19 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 May 2023
Reporting date
19 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 May 2023
Reporting date
19 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 May 2023
Reporting date
19 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .